Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice

ANTONIO RIVERO ROMÁN2026-01-292026-01-29202310.1093/jac/dkad2782-s2.0-85174815007https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/37047Infectious DiseasesMicrobiology (medical)PharmacologyPharmacology (medical)Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practiceresearch article